Supernus, Inc.
corporate_fare Company Profile
Supernus, Inc. (NASDAQ:INDV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 35 items for INDV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 13 rated 8 or above. Recent SEC coverage for INDV spans 8-K, 10-Q, 424B3, S-4/A.
Recent high-impact activity:
- Indivior-Supernus Merger Closes; $650M Term Loan Funds $1B Special Dividend
- Indivior Beats Q3 Estimates With $1.32 EPS, Revenue Up 13% to $356M
- Indivior Q3: Revenue Up 13% to $356M, Net Income $137M Ahead of Nov 2 Supernus Close
- Indivior Posts Record Q3: SUBLOCADE $267M, EPS $1.12, Merger Closes Nov 2
- Indivior Posts Record Q3: SUBLOCADE Up 22%, Adjusted EBITDA Margin Hits 59%
Financial Snapshot
Short Interest & Short Volume
3.63 days to coverFINRA reported short interest of 9,523,819 shares in INDV as of the October 30, 2026 settlement, a 1.2% increase from the prior period — about 3.6 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.